Characteristic | No. (%) of participants* in the Hamilton cohort n = 1092 | No. (%) of participants* in the Brisbane cohort n = 795 | No. (%) of participants* in the Christchurch cohort n = 946 | No. (%) of participants* in the Hamburg cohort n = 1412 |
---|---|---|---|---|
Age, mean ± SD; yr | 66.5 ± 16.6 | 55.2 ± 15.2 | 64.5 ± 12.8 | 62.7 ± 15.6 |
Male sex | 515 (47.2) | 476 (59.9) | 569 (60.1) | 899 (63.7) |
Family history of coronary artery disease | 596 (54.6) | 367 (46.2) | 538 (56.9) | 257 (18.2) |
Hypertension | 767 (70.2) | 397 (49.9) | 566 (59.8) | N/A |
Hypercholesterolemia | 646 (59.2) | 381 (47.9) | 542 (57.3) | N/A |
Diabetes mellitus | 319 (29.2) | 104 (13.1) | 165 (17.4) | 193 (13.7) |
Current smoking | 278 (25.5) | 217 (27.3) | 135 (14.3) | 338 (23.9) |
History of MI | 388 (35.5) | 137 (17.2) | 277 (29.3) | 228 (16.1) |
History of congestive heart failure | 211 (19.3) | 39 (4.9) | 80 (8.5) | 211 (14.9) |
History of angina | 288 (26.4) | 184 (23.1) | 421 (44.5) | N/A |
Detectable hs-cTnI concentration | 941 (86.2) | 708 (88.7) | 888 (93.9) | 1185 (83.9) |
Detectable hs-cTnT concentration | 922 (84.4) | 573 (72.1) | 680 (71.9) | 899 (63.7) |
30-d MI or death† | 177 (16.2) | 47 (5.9) | 225 (23.8) | 276 (19.5) |